MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

in pre-open, page-5

  1. 343 Posts.
    As the next trial is very important do not expect previous share movements to repeat themselves to the same extent. Will not drop as low as before and will make higher highs.

    This time I also expect to have more media coverage than previously shown as the results are becoming more significant. Also more brokers will start to take interest and review the company which (if positive) will propel the share price.




 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.